Browsing Centre for Biochemical Pharmacology by Author "Ulrik, C"
Now showing items 1-5 of 5
-
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
Price, D; Burkill, S; Wang, E; Wechsler, ME; Denton, E; Tran, TN; Martin, N; Katial, R; Barker, P; Maspero, J (2022) -
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both
Price, D; pfeffer, P; Ali, N; Murray, R; Ulrik, C; Tran, T; Maspero, J; Peters, M; Christoff, G; Sadatsafavi, M (2022) -
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.
Chen, W; Tran, TN; Sadatsafavi, M; Murray, R; Wong, NCB; Ali, N; Ariti, C; Bulathsinhala, L; Gil, EG; FitzGerald, JM (2023-09)BACKGROUND: Effectiveness of biologics has neither been established in patients with high oral corticosteroid exposure (HOCS) nor been compared with effectiveness of continuing with HOCS alone. OBJECTIVE: To examine the ... -
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
Burkill, S; Porsbjerg, CM; Bourdin, A; Tran, TN; Martin, N; Katial, R; Barker, P; Wechsler, ME; Maspero, J; Bosnic-Anticevich, S (2022) -
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
Chen, W; Tran, TN; Sadatsafavi, M; Murray, RB; Boon Wong, NC; Ali, N; Ariti, C; Bulathsinhala, L; Garcia Gil, E; FitzGerald, JM (2024-02)